论文部分内容阅读
Objective Taliglucerase alfa is the first approved plant cell-expressed recombinant human protein and is an enzyme replacement therapy indicated for treatment of adults with Type 1 Gaucher disease (GD).In study PB-06-002,safety and efficacy were evaluated in 26 adult patients switched from imiglucerase to taliglucerase alfa.